Skip to main content

The effect of intraoperative goal-directed crystalloid versus colloid administration on perioperative inflammatory markers - a substudy of a randomized controlled trial

Abstract

Background

Excessive perioperative fluid administration may result in iatrogenic endothelial dysfunction and tissue edema, transducing inflammatory markers into the bloodstream. Colloids remain longer in the circulation, requiring less volume to reach similar hemodynamic endpoints compared to crystalloids. Thus, we tested the hypothesis that a goal-directed colloid regimen attenuates the inflammatory response compared to a goal-directed crystalloid regime.

Methods

Patients undergoing moderate- to high-risk open abdominal surgery were randomly assigned to goal-directed lactated Ringer’s solution (n = 58) or a hydroxyethyl starch 6% 130/0.4 (n = 62) fluid regimen. Our primary outcome was perioperative levels of pro- and anti-inflammatory cytokines. Secondary outcome was perioperative levels of white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT) and lipopolysaccharide-binding protein (LBP). Measurements were performed preoperatively, immediate postoperatively, on postoperative day one, two and four.

Results

The areas under the curve of Interleukin (IL) 6 (p = 0.60), IL 8 (p = 0.46), IL 10 (p = 0.68) and tumor necrosis factor α (p = 0.47) levels did not differ significantly between the groups. WBC, CRP and PCT values were also comparable. LBP, although significantly higher in the crystalloid group, remained in the normal range. Patients assigned to crystalloids received a median (IQR) amount of 3905 mL (2880–5288) of crystalloid. Patients assigned to colloids received 1557 mL (1207–2116) of crystalloid and 1250 mL (750–1938) of colloid.

Conclusion

Cytokine and inflammatory marker levels did not differ between goal-directed crystalloid and colloid administration after moderate to high-risk abdominal surgery.

Trial registration

ClinicalTrials.gov (NCT00517127). Registered 16th August 2007.

Peer Review reports

Introduction

Volume replacement is crucial in the perioperative period and has great impact on postoperative outcome [1]. Fluid restriction may cause hypotension and hypoperfusion, leading to organ dysfunction [2]. On the other hand, excessive fluid administration leads to destruction of the endothelial surface layer and consequently to tissue edema with harmful side effects [1, 3, 4].

Goal-directed fluid therapy (GDT), based on optimization of flow-related hemodynamic parameters improves clinical outcome in low to high-risk surgical patients compared to fixed fluid protocols [5, 6]. Specifically, GDT enhances cardiac performance and gut microcirculation while avoiding iatrogenic hyperhydration [1, 7, 8]. In addition to hypervolemia, the inflammatory response due to surgical trauma aggravates degradation of the endothelial barrier, the so-called glycocalyx [9]. Inflammation leads to cytokine release and may thus worsen outcome. For example, high postoperative interleukin (IL) 6 levels are independently associated with postoperative complications [10].

So far in most previously performed GDT studies hemodynamic algorithms were based on colloid bolus administration to improve hemodynamic variables [11]. Colloids better maintain the intravascular oncotic pressure and provide a higher volume effect when used in case of hypovolemia [12]. Goal-directed colloid administration reduces intraoperative fluid requirement and improves cardiac performance compared to crystalloids [13, 14]. Whether this translates into better outcome, specifically in a decreased postoperative inflammatory response, is still a matter of research. The comparison between colloid versus crystalloid based fluid regimens was still lacking. Therefore, we tested the primary hypothesis that perioperative levels of pro- and anti-inflammatory cytokines (IL 6, IL 8, IL 10) and tumor necrosis factor alpha (TNF α) are reduced by goal-directed colloid versus crystalloid administration during the first four postoperative days in patients undergoing moderate to high-risk open abdominal surgery. In addition, we measured white blood cell (WBC) count, C-reactive protein (CRP), procalcitonin (PCT) and lipopolysaccharide-binding protein (LBP) levels.

Materials and methods

This prospective randomized controlled trial was conducted at the Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna, Austria. The Institutional Review Board of the Medical University of Vienna approved it as part of a large multicenter outcome trial, evaluating the effect of goal-directed crystalloid and colloid on postoperative combined morbidity and complications [15]. The Ethical Committee of Medical University of Vienna, Vienna, Austria provided ethical approval for this trial. The trial was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice and registered at ClinicalTrials.gov. (NCT00517127 and EudraCT: 2005–004602-86). A written informed consent was obtained from all patients. The authors have followed the applicable CONSORT guidelines.

For this single center sub-study 120 consecutive eligible patients were included. Patients aged 18 to 80 years, undergoing elective moderate to high-risk open abdominal surgery with American Society of Anesthesiologists (ASA) physical status I-III were included. We excluded patients with severe obesity (body mass index (BMI) > 35 kg.m− 2), cardiac insufficiency (ejection fraction (EF) < 35%), coronary artery disease with angina, severe chronic obstructive pulmonary disease, autoimmune diseases, coagulopathies, renal insufficiency (creatinine clearance < 30 ml.min− 1 or renal replacement therapy), symptoms of infection or sepsis and preoperative CRP higher than 1 mg.dl− 1.

Protocol

Preoperatively all patients received antimicrobial prophylaxis using a single dose of a 2nd generation cephalosporine according to our clinical standards. Anesthetic management was standardized. Standard monitoring included electrocardiography (ECG), invasive blood pressure surveillance, pulse oximetry and esophageal core temperature monitoring. A central venous catheter was inserted when deemed clinically necessary. We used balanced anesthesia with sevoflurane. None of our patients received locoregional anesthesia. According to patients’ requirements additional fentanyl and non-depolarizing neuromuscular blocking were administered. Ventilatory rate was adjusted to maintain end-tidal carbon dioxide partial pressure (etCO2) of 35–40 mmHg. Normothermia was maintained with forced air warming.

Patients were randomized 1:1 to crystalloid (lactated Ringer’s solution) or colloid (hydroxyethyl starch 6% 130/0.4, Voluven, Fresenius Kabi, Germany) group. Randomization was based on computer-generated codes. To conceal allocation, sealed opaque envelopes were opened only shortly before induction of anesthesia.

All patients were given 5–7 ml.kg− 1 of lactated Ringer’s solution during induction of anesthesia followed by 3–5 ml.kg− 1 per hour for maintenance, normalized to ideal body weight (IBW), throughout surgery. We calculated IBW according to the Robinson formula [16]. Thereafter, the randomized fluid, crystalloid or colloid, was esophageal Doppler-guided (Cardiac Q, Deltex Medical Group PLC, Chichester, UK) according to a standard algorithm [11]. This method is based on corrected aortic flow time (FTc) as well as stroke volume (SV) and allows distinguishing whether a patient is a fluid responder or not. If mean arterial pressure (MAP) was below 65 mmHg and no signs of hypovolemia were detected, vasopressors were administrated.

Patients were transferred to post-anesthetic care unit (PACU) or intensive care unit (ICU) at the discretion of the attending anesthesiologist. Fluid management was standardized for the first 2 postoperative hours, in which patients received 2 ml.kg− 1 IBW crystalloid per hour.

Measurements

Demographic and morphometric data were recorded as well as ASA score, medical history, type of surgery and preoperative laboratory values. Duration of anesthesia and surgery were recorded. We also recorded intraoperative fluid requirements, estimated blood loss, transfusion requirements and urinary output. For evaluation of anesthetic management, the total amount of fentanyl, end-tidal sevoflurane concentration, core temperature and postoperative ICU admission were noted. Hemodynamic parameters such as MAP, heart rate (HR), FTc, SV and cardiac output (CO) were recorded at 10-min intervals. The application of phenylephrine use was noted.

The primary outcomes were the areas under the curve (AUCs) of postoperative levels of pro- and anti-inflammatory cytokines IL 6, IL 8, IL 10 and TNF α and their differences between the crystalloid and the colloid group. Secondary outcomes were AUCs of WBC, CRP, PCT and LPB and their differences between the groups. All blood samples for parameter-analyses were obtained before surgery as baseline values (T0), immediately postoperatively (T1) as well as on postoperative days one, two and four (T2, T3 and T4), respectively. For analysis of IL 6, IL 8, IL 10 and TNF α blood samples were centrifuged within 1 h at 1500 G for 15 min and plasma was immediately stored at − 80 °C for later enzyme-linked immunosorbent assay (ELISA) analyses. The serum concentrations of IL 6, IL 8, IL 10 and TNF α were determined according to the manufacturer’s instructions (Human sIL-6 Instant ELISA, Human IL-8/NAP-1 Instant ELISA and Human sIL-10 Instant ELISA, eBioscience, Vienna, Austria, www.ebioscience.com, Human TNF α DuoSet, R&D Systems, Minneapolis, Minnesota, www.rndsystems.com). For that purpose, optical density was measured with a Victor 3 microplate reader at a wavelength of 450 nm. Multiple testing of samples on different plates revealed an intra-assay variability of 2% for IL 6, 2% for IL 8, 3% for IL 10, 1% for TNF α and an inter-assay variability of 1% for IL 6, 3% for IL 8, 2% for IL 10 and 2% for TNF α.

For investigation of WBC, CRP, PCT and LPB separate blood samples were obtained. Their analysis took place immediately after blood sampling as routine laboratory analyses.

Sample size calculation and statistical analysis

Sample size calculations for our trial were based on the study of Steppan and colleagues [17]. They observed a mean (standard deviation, SD) of 74 (50) pg.ml− 1 in IL 6 24 h after surgery in 28 abdominal surgery patients. Assuming a similar coefficient of variation (SD/mean = 0.67) for each of the four cytokines primarily planned for evaluation in our study, we calculated a total of 120 patients in order to obtain a 80% power to detect a 30% reduction in any of the cytokines at an overall 0.05 significance level with 80% power.

Groups were primarily compared for balance in patients’ demographic data, intra-operative characteristics and postoperative variables. Absolute standardized differences (ASD) were calculated for patients’ baseline covariates. Subsequent measurements of intra-operative parameters were first averaged within each patient and then averaged among the patients in each treatment group for descriptive analysis. Normal distribution was assessed with q-q plots and Kolmogorow-Smirnow tests. Normally distributed variables were with unpaired, two-tailed t-tests, otherwise the in case of normally distributed values. Wilcoxon rank-sum test was used for not normally distributed continuous data. Paired comparisons between baseline data and postoperative data were performed with paired sample t-test or Wilcoxon signed-rank test, as applicable. Nominal data were analyzed with chi-square or Fisher’s exact test for low expected cell counts. Data were presented as means ± SD, medians (IQR) or as numbers (percentage) as applicable. Adjustment for multiple testing was performed with the Bonferroni method. A P value < 0.05 was considered statistically significant.

Analysis was conducted with SPSS software (Version 25.0.0, Armonk, NY: IBM Corp). R for Macintosh, Version3.2.1 (R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria) was used to calculate ASD.

Results

A total of 120 patients were included between November 2012 and October 2014: 62 in the colloid group and 58 in the crystalloid group (Fig. 1). At T0 all values were measured. Overall, in the crystalloid group 96% and in the colloid group 95% of the pre-planned blood samples were collected and analyzed.

Fig. 1
figure1

CONSORT 2010 Patient flow chart

Patient’s baseline characteristics did not differ, except for height, BMI with a slightly higher BMI in the colloid group, type of surgery and CRP, also higher in the colloid group (Table 1). Duration of anesthesia and surgery were comparable between both groups. Patients assigned to crystalloid administration received a median of 3905 mL (2880–5288) crystalloids whereas patients assigned to the colloid group received 1557 mL (1207–2116) of crystalloid solution and 1250 mL (750–1938) of colloids. Blood loss, transfusion requirements and urinary output did not differ between the groups. Anesthetic management, MAP and HR did not differ between the groups. FTc, SV and CO were significantly higher in the colloid group compared to the crystalloid group (FTc: 348 ms (334–364) versus 339 ms (321–353), p <  0.01, SV: 91 ml (75–106) versus 76 mL (64 to 90), p <  0.01 and CO: 6.2 ± 1.5 L.min− 1 versus 5.4 ± 1.2 L.min− 1, p <  0.01). The number of patients requiring vasopressor support was comparable between groups. The incidence of postoperative ICU admissions did not differ (62% in the crystalloid versus 58% in the colloid group, p = 0.71) (Table 2).

Table 1 Baseline Characteristics
Table 2 Intraoperative Data

Baseline values of IL 6, IL 8, IL 10 and TNF α in the crystalloid group were comparable to values in the colloid group (IL 6: 0.00 pg.ml− 1 (0.00–2.04) versus 0.00 pg.mL− 1 (0.00–1.75), p = 0.95; IL 8: 4.22 pg.mL− 1 (1.45–8.03) versus 4.83 pg.mL− 1 (1.47–8.35), p = 0.75; IL 10: 0.31 pg.mL− 1 (0.00–3.30) versus 0.43 pg.mL− 1 (0.00–2.02), P = 0.71; TNF α: 17.69 pg.mL− 1 (11.6–41.46) versus 16.27 pg.mL− 1 (8.58–56.62), p = 0.52). Immediate postoperative values of IL 6, 8 and 10 were significantly higher compared to baseline values in both groups (p <  0.01 for all measurements) while TNF α did not show any significant increase in the crystalloid (p = 0.23) and the colloid group (p = 0.13) (Fig. 2). AUCs of IL 6, IL 8, IL 10 and TNF α did not differ significantly between the groups (Table 3).

Fig. 2
figure2

a-d: Pro- and anti-inflammatory cytokines IL 6, IL 8, IL 10 and TNF α over time. 2 A: IL 6, 2 B: IL 8, 2 C: IL 10 and 2 D: TNF α. Data are presented as medians (IQR). Abbreviations: IL – interleukin, TNF α – tumor necrosis factor alpha, POD – postoperative day

Table 3 Areas under the curve of inflammatory markers

WBC values at baseline were 4.7 G.L− 1 (3.7–6.0) in the crystalloid versus 5.0 G.L− 1 (3.9–6.0) in the colloid group (P = 0.50). CRP, PCT and LBP baseline values were also comparable in both groups (CRP: 0.16 mg.dL− 1 (0.06–0.36) versus 0.24 mg.dL− 1 (0.13–0.47), P = 0.05; PCT: 0.05 ng.mL− 1 (0.03–0.06) versus 0.04 ng.mL− 1 (0.03–0.06), P = 0.51; LBP: 5.32 mcg.L− 1 (4.26–6.61) versus 5.46 mcg.L− 1 (4.10–6.81), p = 0.91).

Immediate postoperative values of WBC and PCT were significantly higher compared to the baseline values in both groups (P <  0.01 for all measurements) (Fig. 3).

Fig. 3
figure3

a-d: Inflammatory markers WBC, CRP, PCT and LBP over time. a: WBC, b: CRP, c: PCT and d: LBP. Data are presented as medians (IQR). Abbreviations: WBC – white blood cells, CRP – C-reactive protein, PCT – procalcitonin, LBP – lipopolysaccharide-binding protein, POD – postoperative day. represents significant difference in LBP in the immediate postoperative period between the crystalloid and the colloid group (P = 0.38)

The AUCs for WBC, CRP, PCT and LBP for the time periods from T1 to T4 did not differ significantly between the groups (Fig. 3, Table 3). However, LBP showed significantly higher levels in the crystalloid group in the immediate postoperative period compared to the colloid group (5.3 mcg.L− 1 (4.0–6.7) versus 4.7 mcg.L− 1 (3.3–5.7), p = 0.04). At all other postoperative time points there were no significant differences between the groups (Fig. 3).

Discussion

This trial is a sub-study of a large multi-center randomized trial evaluating the effect of goal-directed crystalloid versus goal-directed colloid fluid administration on a composite of serious complications after moderate to high-risk open abdominal surgery. The overall trial concluded that colloids did not decrease the composite of major complications [15]. Our results are in concordance, as they did not show any differences in perioperative pro- and anti-inflammatory markers between a crystalloid and a colloid fluid regimen.

Despite multimodal care and enhanced recovery programs it still remains challenging to blunt the inflammatory response to surgery [18]. Systemic inflammation after abdominal surgery impairs outcome and therefore many attempts have been made to alter the inflammatory response [10].

Several factors influence the perioperative inflammatory response such as the underlying disease, type and invasiveness of surgery as well as type of anesthesia [19,20,21,22]. The most important factor is the magnitude of surgical trauma and tissue damage, which induce proliferation and activation of immune competent cells, in turn triggering cytokine- and inflammatory marker release [19]. So far, very few trials have specifically investigated the influence of fluid therapy and differences in terms of the type of fluid on the extent of inflammatory marker release.

To investigate the potential influence of goal-directed 6% hydroxyethyl starch versus a lactated Ringer’s solution fluid regimen on inflammatory response, pro- (IL 6, IL 8 and TNF α) and anti-inflammatory cytokine (IL 10) serum levels were measured during the perioperative period. Additionally, we measured WBC, CRP, PCT and LBP.

Generally, the most commonly measured biomarkers are CRP and WBC [23]. If levels of CRP are above 10 mg.dL− 1 after postoperative day four a postoperative infection can be suspected [24]. CRP levels in our study groups increased on the first postoperative day, dropping on the fourth postoperative day to nearly 8 mg.dL− 1 in both study groups.

WBCs are an imprecise marker to detect postoperative complications after major abdominal surgery [10]. A more sensitive parameter in predicting postoperative complications after major abdominal surgery is IL 6 [10]. Surgical trauma and hypoperfusion of the colon are main sources of IL 6 release in colorectal surgery [25]. Noblett demonstrated that GDT during elective colorectal surgery significantly reduced IL 6 levels in comparison to a control group [7]. Yates showed no differences of IL 6 and IL 10 levels between goal-directed colloid and crystalloid fluid therapy during the first 24 h in a subgroup of patients undergoing colorectal surgery [26]. Although, patients in the crystalloid group received significant more volume amount as compared to the colloid group, there was no significant difference in hemodynamic variables [26]. Our patients showed similar courses of IL 6 and IL 10 levels in the immediate postoperative period. In contrast to the trial of Yates, who measured cytokine levels up to the first 24 h after surgery, we extended our measurement period to four postoperative days. We showed comparable circulating IL 6 and IL 10 levels between a GDT crystalloid and colloid administration. These surrogates of inflammatory response imply that gut perfusion during surgery was well preserved with both types of fluid and suggest that the type of fluid might be of minor importance as long as the fluid is administered in a goal-directed fashion.

The fact that TNF α levels in both groups remained stable over the entire measured period further supports our theory. The course of TNF α levels during the perioperative period was in accordance with the study of Szakmany, in which fluid therapy was guided with PiCCO versus central venous pressure in major abdominal surgery in patients at risk for postoperative complications [27]. As TNF α per se triggers glycocalyx degradation [9], we anticipate that TNF α did not influence glycocalyx shedding and thus possible fluid shifts in our study population.

PCT is an early predictive marker for systemic inflammation after abdominal surgery [28]. Values above 1 ng.mL− 1 are associated with postoperative complications such as pneumonia or anastomotic leakage [29]. In our study median PCT levels did not exceed 1 ng.mL− 1 at any measured time point. These results are in concordance with our main study, where infectious complications rate were held low and did not differ between the groups [15]. Moreover, as PCT production can also be induced by tissue hypoperfusion, we might assume that goal-directed fluid administration contributed to low PCT values by optimizing cardiac performance [30].

Furthermore, we measured LBP, a prognostic marker for bacterial infections [31]. Patients in the crystalloid group showed significantly higher levels immediately after surgery; however, the measured values remained within the normal range. Therefore, this difference is most likely not to of clinical importance.

The vascular endothelium is one of the earliest sites involved in the inflammatory response syndrome. An adequate perioperative fluid management has a major impact on the integrity of the glycocalyx [32]. With goal-directed fluid management individualized and time appropriate fluid resuscitation can be achieved, enabling preservation of endothelial surface layer and sufficient organ perfusion, thus improving postoperative outcomes after major surgery [33].

Patients in the colloid group received significantly less fluid (1272 mL), confirming the previously published fluid sparing effect of colloids [13]. However, clinical significance of this difference may be questionable during a perioperative period of nearly five hours. Further, our hemodynamic data showed significantly higher values of SV and CO with colloid administration, though the absolute difference of 15 mL in SV most likely has only limited clinical relevance. It might very well be that the significant differences in SV and CO are the result of our number of patients included in this substudy.

First limitation of our study is that we measured inflammatory markers that reflect the inflammatory response as surrogates and not direct markers of glycocalyx degradation like syndecan-1. Therefore, we cannot draw any conclusions about the preservation of the endothelial surface layer in our patients. Secondly, we did not control postoperative fluid management during the postoperative follow-up period. A further limitation is the time between patient enrolment and submission of our current results. Due to the fact that the main trial has been published recently a delay of our submission occurred [15]. Nevertheless, our results can still be extrapolated to current clinical practice.

Conclusion

In summary, goal-directed hydroxyethyl starch administration did not attenuate the inflammatory response, expressed by cytokine levels of IL 6, IL 8, IL 10 and TNF α in patients undergoing moderate to high-risk open abdominal surgery. WBC, CRP and PTC values did not differ between the different fluid regimes as well.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

barbara.kabon@meduniwien.ac.at

Abbreviations

ASA:

American Society of Anesthesiologists

ASD:

Absolute Standardized Difference

AUC:

Area Under the Curve

BMI:

Body Mass Index

CO:

Cardiac Output

CRP:

C-Reactive Protein

ECG:

Electrocardiography

EF:

Ejection Fraction

ELISA:

Enzyme-Linked Immunosorbent Assay

etCO2 :

End-tidal Carbon Dioxide

FTc:

Corrected Flow Time

GDT:

Goal-directed Therapy

HR:

Heart Rate

IBW:

Ideal Body Weight

ICU:

Intensive Care Unit

IL:

Interleukin

IQR:

Interquartile Range

LBP:

Lipopolysaccharide-Binding Protein

MAP:

Mean Arterial Pressure

PACU:

Post-Anesthetic Care Unit

PCT:

Procalcitonin

PiCCO:

Pulse Contour Cardiac Output

SPSS:

Statistical Package for the Social Sciences

SV:

Stroke Volume

TNF α:

Tumor Necrosis Factor Alpha

TWA:

Time Weighted Average

WBC:

White Blood Cell Count

References

  1. 1.

    Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238(5):641–8.

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. New Engl J Med. 2018;378(24):2263–74.

    Article  Google Scholar 

  3. 3.

    Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109(4):723–40.

    Article  Google Scholar 

  4. 4.

    Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990;18(7):728–33.

    CAS  Article  Google Scholar 

  5. 5.

    Sun Y, Chai F, Pan C, Romeiser JL, Gan TJ. Effect of perioperative goal-directed hemodynamic therapy on postoperative recovery following major abdominal surgery-a systematic review and meta-analysis of randomized controlled trials. Critical Care. 2017;21(1):141.

    Article  Google Scholar 

  6. 6.

    Calvo-Vecino JM, Ripolles-Melchor J, Mythen MG, et al. Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial). Br J Anaesth. 2018;120(4):734–44.

    CAS  Article  Google Scholar 

  7. 7.

    Noblett SE, Snowden CP, Shenton BK, Horgan AF. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg. 2006;93(9):1069–76.

    CAS  Article  Google Scholar 

  8. 8.

    Kimberger O, Arnberger M, Brandt S, et al. Goal-directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology. 2009;110(3):496–504.

    CAS  Article  Google Scholar 

  9. 9.

    Kolarova H, Ambruzova B, Svihalkova Sindlerova L, Klinke A, Kubala L. Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediat Inflamm. 2014;2014:694312.

    Article  Google Scholar 

  10. 10.

    Rettig TC, Verwijmeren L, Dijkstra IM, Boerma D, van de Garde EM, Noordzij PG. Postoperative Interleukin-6 level and early detection of complications after elective major abdominal surgery. Ann Surg. 2016;263(6):1207–12.

    Article  Google Scholar 

  11. 11.

    Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97(4):820–6.

    Article  Google Scholar 

  12. 12.

    Jacob M, Chappell D, Rehm M. Clinical update: perioperative fluid management. Lancet. 2007;369(9578):1984–6.

    Article  Google Scholar 

  13. 13.

    Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 2013;110(2):231–40.

    CAS  Article  Google Scholar 

  14. 14.

    Orbegozo Cortes D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg. 2015;120(2):389–402.

    CAS  Article  Google Scholar 

  15. 15.

    Kabon B, Sessler DI, Kurz A, et al. Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity: A Randomized Trial. Anesthesiology. 2019;130(5):728–44.

  16. 16.

    Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm. 1983;40(6):1016–9.

    CAS  PubMed  Google Scholar 

  17. 17.

    Steppan J, Hofer S, Funke B, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165(1):136–41.

    Article  Google Scholar 

  18. 18.

    Wilmore DW. From Cuthbertson to fast-track surgery: 70 years of progress in reducing stress in surgical patients. Ann Surg. 2002;236(5):643–8.

    Article  Google Scholar 

  19. 19.

    Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109–17.

    CAS  Article  Google Scholar 

  20. 20.

    Veenhof AA, Sietses C, von Blomberg BM, et al. The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial. Int J Color Dis. 2011;26(1):53–9.

    CAS  Article  Google Scholar 

  21. 21.

    Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg. 1997;85(6):1394–8.

    CAS  Article  Google Scholar 

  22. 22.

    Wichmann MW, Huttl TP, Winter H, et al. Immunological effects of laparoscopic vs open colorectal surgery: a prospective clinical study. Arch Surg. 2005;140(7):692–7.

    Article  Google Scholar 

  23. 23.

    Watt DG, Horgan PG, McMillan DC. Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review. Surgery. 2015;157(2):362–80.

    Article  Google Scholar 

  24. 24.

    Santonocito C, De Loecker I, Donadello K, et al. C-reactive protein kinetics after major surgery. Anesth Analg. 2014;119(3):624–9.

    CAS  Article  Google Scholar 

  25. 25.

    Baigrie RJ, Lamont PM, Whiting S, Morris PJ. Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg. 1993;166(3):248–51.

    CAS  Article  Google Scholar 

  26. 26.

    Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth. 2014;112(2):281–9.

    CAS  Article  Google Scholar 

  27. 27.

    Szakmany T, Toth I, Kovacs Z, et al. Effects of volumetric vs. pressure-guided fluid therapy on postoperative inflammatory response: a prospective, randomized clinical trial. Intensive Care Med. 2005;31(5):656–63.

    Article  Google Scholar 

  28. 28.

    Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand. 2005;49(2):191–6.

    CAS  Article  Google Scholar 

  29. 29.

    Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94(6):767–73.

    CAS  Article  Google Scholar 

  30. 30.

    Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185–8.

    CAS  Article  Google Scholar 

  31. 31.

    Villar J, Perez-Mendez L, Espinosa E, et al. Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PloS one. 2009;4(8):e6818.

    Article  Google Scholar 

  32. 32.

    Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69(7):777–84.

    CAS  Article  Google Scholar 

  33. 33.

    Pearse RM, Harrison DA, MacDonald N, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. Jama. 2014;311(21):2181–90.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

Assistance with this article: we thank Bianca Tudor, MD, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria for her support in laboratory skills, performing ELISAs.

Funding

Medical University of Vienna.

Partially funded by Fresenius Kabi. Deltex Medical provided oesophageal Doppler monitors and disposables.

The sponsors were not involved in protocol development, data acquisition, or data analysis.

Author information

Affiliations

Authors

Contributions

All authors have read and approved the manuscript. M.O.: patient recruitment, data acquistion and prepratation of the manuscript. A.K.: study protocol, writing and preparation of the manuscript. B.K.: study protocol, writing and preparation of the manuscript, statistical analyisis. G.R.: data analysis, revision of the manuscript. O.K.: data analysis, preparation of the manuscript. O.Z.: patient recruitment, data acquisition, data management. A.B.: patient recruitment, data acquisition, revsion the manuscript. C.R.: data acquistion, revision of the manuscript. A.S.: patient recruitment, revision of the manuscript. E.F: study protocol, writing and preparation of the manuscript.

Corresponding author

Correspondence to Barbara Kabon.

Ethics declarations

Ethics approval and consent to participate

The main trial was approved by the local ethics committee of the Medical University of Vienna in 2005 (EK 431/2005) and was registered at ClinicalTrials.gov (NCT00517127) and EudraCT (2005–004602-86). A written informed consent was obtained from all patients prior to participation.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Obradovic, M., Kurz, A., Kabon, B. et al. The effect of intraoperative goal-directed crystalloid versus colloid administration on perioperative inflammatory markers - a substudy of a randomized controlled trial. BMC Anesthesiol 20, 210 (2020). https://doi.org/10.1186/s12871-020-01126-3

Download citation